Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1960 1
1962 1
1963 1
1964 3
1965 1
1973 1
1974 1
1975 2
1976 3
1977 4
1978 1
1980 10
1981 4
1982 2
1983 3
1984 6
1985 6
1986 14
1987 9
1988 14
1989 11
1990 20
1991 17
1992 22
1993 22
1994 37
1995 36
1996 35
1997 41
1998 47
1999 48
2000 73
2001 99
2002 80
2003 121
2004 116
2005 184
2006 223
2007 262
2008 370
2009 388
2010 468
2011 593
2012 664
2013 800
2014 959
2015 1058
2016 1100
2017 1317
2018 1601
2019 1763
2020 2141
2021 2549
2022 3008
2023 2877
2024 3137
2025 65

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23,698 results

Results by year

Filters applied: . Clear all
Page 1
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: yang f. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Safety and efficacy of three enteral feeding strategies in patients with severe stroke in China (OPENS): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.
Zhao J, Yuan F, Song C, Yin R, Chang M, Zhang W, Zhang B, Yu L, Jia Y, Ma Y, Song Y, Wang C, Song C, Wang X, Shang L, Yang F, Jiang W; OPENS Trial Investigators. Zhao J, et al. Among authors: yang f. Lancet Neurol. 2022 Apr;21(4):319-328. doi: 10.1016/S1474-4422(22)00010-2. Epub 2022 Feb 24. Lancet Neurol. 2022. PMID: 35219379 Clinical Trial.
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
McDowell PJ, Diver S, Yang F, Borg C, Busby J, Brown V, Shrimanker R, Cox C, Brightling CE, Chaudhuri R, Pavord ID, Heaney LG; Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium). McDowell PJ, et al. Among authors: yang f. Lancet Respir Med. 2021 Oct;9(10):1174-1184. doi: 10.1016/S2213-2600(21)00004-7. Epub 2021 May 7. Lancet Respir Med. 2021. PMID: 33971168
2-Benzyl-6-benz-yloxypyridazin-3(2H)-one.
Ju ZY, Jiang WX, Yang FL. Ju ZY, et al. Among authors: yang fl. Acta Crystallogr Sect E Struct Rep Online. 2011 May 1;67(Pt 5):o1042. doi: 10.1107/S1600536811011597. Epub 2011 Apr 7. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 21754369 Free PMC article.
High-Strength Hydrogel Attachment through Nanofibrous Reinforcement.
Zhao J, Kirillova A, Kelly CN, Xu H, Koshut WJ, Yang F, Gall K, Wiley BJ. Zhao J, et al. Among authors: yang f. Adv Healthc Mater. 2021 Feb;10(4):e2001119. doi: 10.1002/adhm.202001119. Epub 2020 Sep 16. Adv Healthc Mater. 2021. PMID: 32940005
23,698 results
You have reached the last available page of results. Please see the User Guide for more information.